Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunostimulation in cancer patients.

Y Yamamura, I Azuma

    Advances in Experimental Medicine and Biology
    |January 1, 1983
    PubMed
    Summary

    Cancer immunotherapy shows promise by boosting immune status, but clinical trial results vary. Further research is needed to develop more effective cancer treatments and combined therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Injection of cell-wall skeleton of Mycobacterium bovis BCG draining to a sentinel lymph node eliminates both lymph node metastases and the primary transplanted tumor.

    Drug discoveries & therapeutics·2012
    Same author

    Immune response against cell-wall skeleton of Mycobacterium bovis BCG at the inoculation site and peripheral lymphoid organs.

    Drug discoveries & therapeutics·2012
    Same author

    Phagocytosis plays a dual role in activating dendritic cells; digestive production of active Toll-like receptor ligands and cooperation with Toll-like receptor signaling.

    Drug discoveries & therapeutics·2012
    Same author

    Dorzolamide, a topical carbonic anhydrase inhibitor: a two-week dose-response study in patients with glaucoma or ocular hypertension.

    Journal of glaucoma·2009
    Same author

    Two receptor theory in innate immune activation: studies on the receptors for bacillus Culmet Guillen-cell wall skeleton.

    Archivum immunologiae et therapiae experimentalis·2001
    Same author

    Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton.

    International immunopharmacology·2001

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Cancer patients often have a compromised immune system.
    • Immunopotentiators demonstrate antitumor activity in preclinical models.
    • Clinical efficacy of immunotherapies has been inconsistent in trials.

    Purpose of the Study:

    • To evaluate the potential of enhancing depressed immune status in cancer patients.
    • To critically assess the effectiveness of existing immunotherapies in clinical settings.
    • To identify future directions for improving cancer immunotherapy.

    Main Methods:

    • Review of experimental tumor systems (in vivo and in vitro).
    • Analysis of well-designed controlled clinical trials.
    • Exploration of novel immunotherapeutic strategies.

    Main Results:

    • Immunopotentiators effective in preclinical studies are not always successful in clinical trials.
    • Overestimation of current immunotherapy may lead to overlooking other effective treatments.
    • Significant discrepancies exist between experimental and clinical outcomes.

    Conclusions:

    • Cancer immunotherapy is not currently a primary treatment modality.
    • Extensive research is required for developing more effective immunostimulation.
    • Combined immunotherapy or combination with other modalities warrants further investigation.

    Related Experiment Videos